EUVIMEDEUVIMED entdecken
Crossref

Development of an engineered Bacillus subtilis strain for antibiotic‐free sucrose isomerase production

Mingyu Li, Xiaopeng Ren, Ming Xu, Sitong Dong, Xianzhen Li, Xiaoyi Chen, Conggang Wang iD, Fan Yang

Biotechnology Journal · 2024

DOI: 10.1002/biot.202400178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Mingyu Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Engineering, Dalian Polytechnic University, Dalian, China. Hauptthemen laut MEDLINE: Bacillus subtilis, Isomaltose, Glucosyltransferases, Sucrose. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sucrose isomerase (SIase) catalyzes the hydrolysis and isomerization of sucrose into isomaltulose, a functional sugar extensively used in the food industry. However, the lack of safe and efficient heterologous expression systems for SIase has constrained its production and application. In this study, an engineered Bacillus subtilis strain for antibiotic‐free SIase production was developed via a food‐grade expression system. First, the B. subtilis strain TEA was modified through the CRISPR/Cas9 system, resulting in a mutant strain TEA4, which exhibited enhanced capabilities for recombinant protein expression. For efficient and safe production of SIase, different constitutive and inducible promoters were evaluated. The maltose‐inducible promoter Poglv was found to have an extracellular SIase activity of 21.7 U mL ‐1 in engineered strain TEA4. Subsequent optimization of the culture medium further increased SIase activity to 26.4 U mL ‐1 during shake flask cultivation. Eventually, using the crude enzyme solution of the engineered strain in biotransformation reactions resulted in a high yield of isomaltulose under high concentrations sucrose, achieving a maximum yield of 83.1%. These findings demonstrated an engineered B. subtilis strain for antibiotic‐free SIase production, paving the way for its scale‐up industrial production and application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus subtilisIsomaltoseGlucosyltransferasesSucroseRecombinant ProteinsMetabolic EngineeringPromoter Regions, GeneticCRISPR-Cas SystemsBacterial Proteins

Stichwörter der Autor:innen

Bacillus subtilisSucrose isomerasebiotransformation reactionexpression systempromoter

Substanzen

sucrose isomeraseIsomaltoseisomaltuloseGlucosyltransferasesSucroseRecombinant ProteinsBacterial Proteins

Autor:innen und Institutionen

  • School of Biological Engineering, Dalian Polytechnic University, Dalian, China.

ORCID-Profile: Conggang Wang

Zitieren

APA

Li, M., Ren, X., Xu, M., Dong, S., Li, X., Chen, X., Wang, C., & Yang, F. (2024). Development of an engineered Bacillus subtilis strain for antibiotic‐free sucrose isomerase production. Biotechnology Journal. https://doi.org/10.1002/biot.202400178

Vancouver

Li M, Ren X, Xu M, Dong S, Li X, Chen X, et al. Development of an engineered Bacillus subtilis strain for antibiotic‐free sucrose isomerase production. Biotechnology Journal. 2024. doi:10.1002/biot.202400178

BibTeX
@article{Li2024,
  author = {Li, Mingyu and Ren, Xiaopeng and Xu, Ming and Dong, Sitong and Li, Xianzhen and Chen, Xiaoyi and Wang, Conggang and Yang, Fan},
  title = {Development of an engineered Bacillus subtilis strain for antibiotic‐free sucrose isomerase production},
  journal = {Biotechnology Journal},
  year = {2024},
  doi = {10.1002/biot.202400178}
}
Kostenlos starten →